FDA NDC Directory · JSON-LD · Markdown

Tazorac

NDC 16110-042 · HUMAN PRESCRIPTION DRUG · GEL

Generic nametazarotene
Labeler / ManufacturerAlmirall, LLC
Marketing categoryNew Drug Application (innovator) · App NDA020600
Dosage form / routeGEL · CUTANEOUS
Active ingredientsTAZAROTENE (1 mg/g)
Marketing started20200221
Package count2

External sources

Source: openFDA. Public-domain (CC0).